An update on novel antiplatelets in vascular patients
Acetylsalicylic acid, clopidogrel and cilostazol are well-established agents inhibiting the normal function of platelets with known advantages and limitations. The development of novel antiplatelet agents aims in providing equal or superior outcomes for patients and simultaneously minimize side effe...
Saved in:
Published in | Current pharmaceutical design |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United Arab Emirates
01.01.2018
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!